Group President, International @ Responsible for Canada, LatAm, Japan, Asia Pac, & EEMEA with 2014 sales $1.7Bn and 4,500 employees. From 2011 - 2013, also led the European business ($1Bn sales) as part of the International Group. Corporate Officer, member of Executive Leadership Team, reporting to the Chairman & CEO From September 2011 to Present (4 years 4 months) SingaporeSenior VP & President, Asia Pacific Human Health @ Established APAC HQ in Singapore in August 2007, installed new leadership & capabilities to revive growth for pharma & vaccines (‘09 revenues $1.3Bn). After the $41Bn merger with Schering-Plough in 2009, led the combined $2Bn pharma & vaccines business across AP (excl. China, Japan). From September 2006 to May 2011 (4 years 9 months) Vice President, Oncology Business Unit @ P&L responsibility for $2.3Bn BU. Led team of 500+; franchise incl. two blockbusters brands (Taxotere, Eloxatin). From January 2006 to September 2006 (9 months) Vice President, US Urology Business Unit & Puerto Rico Operations @ P&L responsibility for >$500M BU. Managed two alliances, led team of 600+, incl. specialty & primary care sales teams. Also led Puerto Rico business for Sanofi. From October 2004 to December 2005 (1 year 3 months) Vice President, Bone & CNS Business Unit @ P&L responsibility for $1.4Bn BU, team of 600+ (sales, marketing, medical affairs). Led US alliance with Procter & Gamble on Actonel From May 2004 to September 2004 (5 months) Vice President, Sales, Respiratory Business @ Led Eastern US primary care sales sales team of 1100 people, $2Bn sales From September 2003 to April 2004 (8 months) Managing Director @ Hoechst Marion Roussel & Rhone-Poulenc Rorer merged to create Aventis, which was the 2nd largest MNC Pharma co in India, with sales of $140M, 1,250 employees, & listed on the Bombay Stock Exchange. As Managing Director, Aventis Pharma, was responsible for leading operations in India, Nepal & Sri Lanka. Member of the Board of Directors. From November 2000 to August 2003 (2 years 10 months) Chief Financial Officer, Executive Director @ Member of the Board of Directors. Led Finance and IT operations. From April 1997 to October 2000 (3 years 7 months) Director, Corporate Planning @ Hoechst AG was one of the world’s largest chemical companies with a broad portfolio of chemical and pharmaceutical businesses. 1995 sales were $36Bn and the company had 170,000 employees. Led development and implementation of the Strategic Management Process and enterprise portfolio reviews leading to the transformation of the Hoechst group. From February 1995 to March 1997 (2 years 2 months) Marketing Manager @ Bulk Pharmaceuticals Division: Led global sales, marketing & BD for a start-up active ingredient business. From January 1993 to January 1995 (2 years 1 month) Finance Manager @ Bulk Pharmaceuticals Division: Led Finance & IT operations for a start-up active ingredient business including a 50/50 JV with Boot plc From December 1990 to December 1992 (2 years 1 month) Analyst @ Planning Analyst, Corporate Development (1989) Financial Analyst, Corporate Controller's office (1988) From January 1988 to November 1989 (1 year 11 months) Senior Auditor @ Articleship for the Institute of Chartered Accountants in England & Wales From September 1983 to September 1987 (4 years 1 month)

Ramesh Subrahmanian is skilled in: Pharmaceutical Industry, Medical Devices, Management, Cross-functional Team Leadership, Business Strategy, Mergers & Acquisitions, Board of Directors, Sales, Product Launch, Market Access, Strategy, Biotechnology, Post-merger integration, Business Transformation, Finance